Abbott Laboratories (ABT) Minority Interest (2009 - 2026)

Abbott Laboratories' Minority Interest history runs 18 years deep, the most recent figure standing at $640.0 million for Q1 2026.

• In Q1 2026, Minority Interest rose 152.96% year-over-year to $640.0 million; the TTM figure through Mar 2026 stood at $640.0 million (up 152.96% YoY), while the FY2025 annual figure was $641.0 million, up 170.46% from the prior year.
• Minority Interest came in at $640.0 million for Q1 2026 at Abbott Laboratories, roughly flat from $641.0 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $641.0 million in Q4 2025 to a low of $209.0 million in Q3 2022.
• A 5-year average of $283.8 million and a median of $232.0 million in 2024 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest slipped 3.48% in 2023 and surged 170.46% in 2025, its largest moves.
• Abbott Laboratories' Minority Interest stood at $219.0 million in 2022, then rose by 2.28% to $224.0 million in 2023, then grew by 5.8% to $237.0 million in 2024, then soared by 170.46% to $641.0 million in 2025, then declined by 0.16% to $640.0 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered $640.0 million, $641.0 million, and $310.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison